SNAP‐23 and VAMP‐3 contribute to the release of IL‐6 and TNFα from a human synovial sarcoma cell line
- 13 December 2013
- journal article
- research article
- Published by Wiley in The FEBS Journal
- Vol. 281 (3) , 750-765
Abstract
Fibroblast‐like synoviocytes are important mediators of inflammatory joint damage in arthritis through the release of cytokines, but it is unknown whether their exocytosis from these particular cells is SNARE‐dependent. Here, the complement of soluble N‐ethylmaleimide‐sensitive factor attachment protein receptors (SNAREs) in human synovial sarcoma cells (SW982) was examined with respect to the secretion of interleukin‐6 (IL‐6) and tumour necrosis factor α (TNFα), before and after knockdown of a synaptosome‐associated protein of molecular mass 23 kDa (SNAP‐23) or the vesicle‐associated membrane protein 3 (VAMP‐3). Wild‐type SW982 cells expressed SNAP‐23, VAMP‐3, syntaxin isoforms 2–4 and synaptic vesicle protein 2C (SV2C). These cells showed Ca2+‐dependent secretion of IL‐6 and TNFα when stimulated by interleukin‐1β (IL‐1β) or in combination with K+ depolarization. Specific knockdown of SNAP‐23 or VAMP‐3 decreased the exocytosis of IL‐6 and TNFα; the reduced expression of SNAP‐23 caused accumulation of SV2 in the peri‐nuclear area. A monoclonal antibody specific for VAMP‐3 precipitated SNAP‐23 and syntaxin‐2 (and syntaxin‐3 to a lesser extent). The formation of SDS‐resistant complexes by SNAP‐23 and VAMP‐3 was reduced upon knockdown of SNAP‐23. Although the syntaxin isoforms 2, 3 and 4 are expressed in SW982 cells, knockdown of each did not affect the release of cytokines. Collectively, these results show that SNAP‐23 and VAMP‐3 participate in IL‐1β‐induced Ca2+‐dependent release of IL‐6 and TNFα from SW982 cells.Structured digital VAMP-3 physically interacts with syntaxin 2 and SNAP-23 by anti-bait coimmunoprecipitation (View interaction)Keywords
This publication has 55 references indexed in Scilit:
- A botulinum toxin–derived targeted secretion inhibitor downregulates the GH/IGF1 axisJournal of Clinical Investigation, 2012
- Osteoarthritis year 2011 in review: biologyOsteoarthritis and Cartilage, 2012
- Retargeted Clostridial Neurotoxins as Novel Agents for Treating Chronic DiseasesBiochemistry, 2011
- A peripheral neuroimmune link: glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-α, and RANTES in cultured human synoviocytesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Engineering botulinum neurotoxin to extend therapeutic interventionProceedings of the National Academy of Sciences, 2009
- Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype FBiochemistry, 2009
- Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into NeuronsMolecular Biology of the Cell, 2008
- Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFαJournal of Cell Biology, 2007
- Cytokines in the pathogenesis of rheumatoid arthritisNature Reviews Immunology, 2007
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006